Interestingly, the expression of TFPI-2 decreases with increasing degree of malignancy in multiple neoplasms (gliomas, breast, colon, pancreatic, laryngeal, endometrial and renal cancers) [33, 53]. This evidence concerns the gene TFPI2 and central nervous system cancer.